Plain-English translation of NCT06463561 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether CPAP (a machine that gently blows air into your airways while you sleep) can improve your cholesterol levels and reduce uric acid in your blood. You have both high cholesterol and moderate-to-severe obstructive sleep apnea โ a condition where your breathing stops repeatedly during sleep. The study will follow you for 12 months to see if the treatment, combined with standard cholesterol medications and healthy lifestyle changes, helps your body better manage these two conditions.
Sleep apnea and high cholesterol often occur together and increase your risk of heart disease. Doctors know that CPAP helps people breathe better at night, but they want to understand whether this treatment also improves cholesterol and uric acid levels โ which could offer additional heart health benefits beyond just better sleep.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
Half of the participants will receive a CPAP machine to use nightly for 12 months, along with standard cholesterol medications and advice on healthy diet and exercise. The other half will receive only the standard cholesterol medications and lifestyle advice without the machine. You'll have regular visits to the hospital to have blood tests, answer questions about your health and quality of life, and allow doctors to measure how well the treatment is working.
AI-generated summary from trial data ยท Jun 11, 2026 ยท Not medical advice
Spain